Atlas Trials

Indolent Systemic Mastocytosis

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Indolent Systemic Mastocytosis

RecordFirmDate
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis (NCT04910685)Blueprint Medicines Corporation2021-11-30
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis (NCT04655118)Telios Pharma, Inc.2020-10-22
Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment (NCT04333108)AB Science2020-07-01
Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis (NCT03770273)National Institute of Allergy and Infectious Diseases (NIAID)2019-06-19
Adaptation of the Questionnaire "Regarding Patient's Quality of Life With Mastocytosis" in the French Language (NCT03632811)University Hospital, Toulouse2018-11-14
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002 (NCT02808793)Allakos Inc.2016-06-01
Treatment of Indolent Systemic Mastocytosis With PA101 (NCT02478957)Patara Pharma2015-06-01
Midostaurin in Indolent Systemic Mastocytosis (NCT01920204)University Medical Center Groningen2013-08-01
Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis (NCT00814073)AB Science2008-12-01

Track Indolent Systemic Mastocytosis automatically

Every clearance here is in the API, with alerts when new ones post.